Semin Thromb Hemost 2014; 40(01): 060-065
DOI: 10.1055/s-0033-1363468
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism

Giuseppe Lippi
1   Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
,
Emmanuel J. Favaloro
2   Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, New South Wales, Australia
,
Tiziana Meschi
3   Department of Clinical Sciences, University of Parma, Parma, Italy
,
Camilla Mattiuzzi
4   Service of Clinical Governance, General Hospital of Trento, Trento, Italy
,
Loris Borghi
3   Department of Clinical Sciences, University of Parma, Parma, Italy
,
Gianfranco Cervellin
5   Emergency Department, Academic Hospital of Parma, Parma, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
16. Dezember 2013 (online)

Abstract

Cigarette smoking is the most important cause of premature death, and it is currently listed as a major independent risk factor for cardiovascular disease. Because of restrictive measures and widespread control policies, tobacco companies are now using aggressive marketing strategies in favor of smokeless tobacco, including electronic nicotine delivery systems, which are also known as electronic cigarettes or e-cigarettes. Although the regular use of these devices appears less hazardous than traditional cigarettes or other forms of smokeless tobacco, recent studies have shown that various potentially harmful substances, especially nicotine, ultraparticles, and volatile organic compounds, may be effectively inhaled or liberated in exhaled air during repeated e-cigarette puffing. This would enhance the risk of cardiac arrhythmias and hypertension, which may predispose some users to increased risk of cardiovascular events, which may be further magnified by other potential adverse effects such as arrhythmias, increased respiratory, and flow respiratory resistance. Some cases of intoxication have also been described, wherein large amounts of nicotine and other harmful compounds may be effectively absorbed. As the use of e-cigarettes is continuously rising, and it is also considered a potentially effective method for smoking cessation, more focused research is urgently needed to definitely establish the cardiovascular safeness of these devices.

 
  • References

  • 1 Go AS, Mozaffarian D, Roger VL , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013; 127 (1) e6-e245
  • 2 Greenland P, Alpert JS, Beller GA , et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010; 122 (25) e584-e636
  • 3 Piano MR, Benowitz NL, Fitzgerald GA , et al; American Heart Association Council on Cardiovascular Nursing. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 2010; 122 (15) 1520-1544
  • 4 Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med 2011; 365 (3) 193-195
  • 5 Etter JF, Bullen C, Flouris AD, Laugesen M, Eissenberg T. Electronic nicotine delivery systems: a research agenda. Tob Control 2011; 20 (3) 243-248
  • 6 Hadwiger ME, Trehy ML, Ye W, Moore T, Allgire J, Westenberger B. Identification of amino-tadalafil and rimonabant in electronic cigarette products using high pressure liquid chromatography with diode array and tandem mass spectrometric detection. J Chromatogr A 2010; 1217 (48) 7547-7555
  • 7 Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction 2013; 108 (9) 1671-1679
  • 8 Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control 2013; ; [Epub ahead of print]
  • 9 Kim HJ, Shin HS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2013; 1291: 48-55
  • 10 Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS ONE 2013; 8 (3) e57987
  • 11 Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010; 19 (2) 98-103
  • 12 Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010; 19 (8) 1945-1953
  • 13 Schripp T, Markewitz D, Uhde E, Salthammer T. Does e-cigarette consumption cause passive vaping?. Indoor Air 2013; 23 (1) 25-31
  • 14 Ingebrethsen BJ, Cole SK, Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol 2012; 24 (14) 976-984
  • 15 Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013; 15 (1) 158-166
  • 16 Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013; 108 (6) 1115-1125
  • 17 Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013; 15 (10) 1737-1744 [Epub ahead of print]
  • 18 Yatsuya H, Folsom AR ; ARIC Investigators. Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2010; 172 (5) 600-605
  • 19 Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 2009; 339: b3060
  • 20 Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141 (6) 1400-1406
  • 21 Gennimata SA, Palamidas A, Kaltsakas G , et al. Acute effect of e-cigarette on pulmonary function in healthy subjects and smokers. [Abstract] Eur Respir J 2012; 40 (Suppl. 56) 189S
  • 22 Farsalinos K, Tsiapras D, Kyrzopoulos S , et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. . [Abstract] Eur Heart J 2012; 33 (Suppl. 01) 203
  • 23 Hua M, Alfi M, Talbot P. Health-related effects reported by electronic cigarette users in online forums. J Med Internet Res 2013; 15 (4) e59
  • 24 Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013; 15 (1) 267-270
  • 25 Flouris AD, Chorti MS, Poulianiti KP , et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013; 25 (2) 91-101
  • 26 Monroy AE, Hommel E, Smith ST, Raji M. Paroxysmal atrial fibrillation following electronic cigarette use in an elderly woman. Clin Geriatr 2012; 20 (3) 28-32
  • 27 Cervellin G, Luci M, Bellini C, Lippi G. Bad news about an old poison. A case of nicotine poisoning due to both ingestion and injection of the content of an electronic cigarette refill. Emerg Care J 2013; 9 (2)
  • 28 Lippi G, Franchini M, Banfi G. Biochemistry and physiology of anabolic androgenic steroids doping. Mini Rev Med Chem 2011; 11 (5) 362-373
  • 29 Lippi G, Banfi G. Doping and thrombosis in sports. Semin Thromb Hemost 2011; 37 (8) 918-928
  • 30 Lippi G, Sanchis-Gomar F, Cervellin G. Rest heart rate and mortality: more physical exercise for the rabbit?. Int J Cardiol 2013; 165 (2) 358
  • 31 Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010; 12 (9) 905-912